SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following the European Commission's conditional authorization of ANKTIVA, significantly expanding its market to 33 countries for hard-to-treat bladder cancer. The community is buzzing with intensifying expectations of a massive short squeeze and further global approvals, anticipating a substantial re-evaluation of the stock as a globally validated oncology company.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc (FJET) is rallying as its IPO quiet period recently concluded, intensifying community debate around a potential short squeeze driven by its tiny float and high short interest, with investors also eyeing an anticipated FAA Space Launch license and broader sector tailwinds from the rumored Space X IPO.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending amidst strong community speculation over activist investor Nelson Peltz's comments on its undervaluation, driving discussions of a potential buyout or short squeeze following recent market movements.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its earnings report delivered a revenue beat but lowered profit guidance, fueling a sell-off amid broader software sector concerns. The community is sharply divided between those predicting further declines due to acquisition costs and others viewing the dip as a significant buying opportunity, citing strong cybersecurity demand amplified by AI threats.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a significant increase in institutional ownership by Cormorant Asset Management, seen by the community as a strong validation of its 'best-in-class' nanobody platform. Investors are keenly anticipating the upcoming investor day and clinical data updates, fueling speculation about a potential re-rating and short squeeze due to its perceived undervaluation and high short interest.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly anticipates its BLA resubmission for Deramiocel by month-end, following robust Phase 3 HOPE-3 data for Duchenne Muscular Dystrophy. Investors are closely watching for this regulatory milestone, alongside increasing institutional ownership and ongoing discussions around broader FDA consistency that could impact biotechs like CAPR.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending following news of its multi-year U.S. brewing and commercial partnership with the Carlsberg Group, particularly for CBD beverages. Community discussion centers on whether this strategic collaboration signifies a major beverage market expansion and future cannabis entry for big alcohol, or if it's a non-committal deal diverting from core cannabis sector challenges.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as conversations buzz around promising "physical silicon results" for its Mears Silicon Technology (MST) in Gate-All-Around (GAA) nanosheets, hinting at significant power savings for AI chips, and its GaN-on-Si concept advancing to a proposal stage. This technical progress, coupled with unprecedented trading volume and management's renewed confidence with performance-linked bonuses, fuels a community debate between long-awaited commercial breakthroughs and concerns over the pre-revenue company's history of speculative hype.

PENN Entertainment, Inc. engages in the provision of integrated entertainment, sports content, and casino gaming services. It operates through the following business segments: Northeast, South, West, Midwest, Interactive, and Other. The Northeast segment includes Ameristar East Chicago, Hollywood Casino, Hollywood Gaming, Marquee, and Plainridge Park Casino operations. The South segment manages 1st Jackpot Casino, Ameristar Vicksburg, Boomtown, Hollywood Casino Gulf Coast, Hollywood Casino Tunica, L’Auberge, and Margaritaville Resort Casino. The West segment is involved in Ameristar Black Hawk, Cactus Petes and Horseshu, M Resort Spa Casino, and Zia Park Casino operations. The Midwest segment focuses on Ameristar Council Bluffs, Argosy Casino, Hollywood Casino, Prairie State Gaming, and River City Casino operations. The Interactive segment refers to an online gaming portfolio which includes ESPN BET, Hollywood Casino, theScore Bet, and PENN Game Studios. The Other segment consists of stand-alone racing operations, namely Sanford-Orlando Kennel Club, Sam Houston, and Valley Race Park. The company was founded by Peter M. Carlino in 1982 and is headquartered in Wyomissing, PA.

PENN Entertainment Inc

PENN Entertainment Inc.

PENN Entertainment is trending due to widespread shareholder discontent following the costly termination of its ESPN Bet partnership and rebranding to theScore Bet, fueling calls for CEO Jay Snowden's removal. The community is actively discussing the stock's multi-year lows and advocating for a spin-off of the struggling digital betting segment to prioritize its stable regional casino operations.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop (WING) is trending after reporting a mixed Q4, with an EPS beat but a revenue miss and a conservative domestic same-store sales outlook. Despite the mixed results, the stock has shown significant relative strength and upward price action, fueling community discussions about a potential short squeeze and prompting analyst upgrades that emphasize its international growth and operational efficiency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Addus HomeCare (ADUS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

Public Sector Pension Investment Board Boosts Holdings in Addus HomeCare Corporation $ADUS

Public Sector Pension Investment Board increased its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 14.4% during the 3rd quarter, according to the company in its most...

Short Interest in Addus HomeCare Corporation (NASDAQ:ADUS) Increases By 20.1%

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) saw a large increase in short interest in January. As of January 30th, there was short interest totaling 929,786 shares, an increase of...

Addus HomeCare (ADUS) Expected to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) will be releasing its Q4 2025 earnings before the market opens on Monday, February 23. (View Earnings Report at...

Addus HomeCare Corporation $ADUS Stock Position Raised by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC lifted its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 6.2% during the third quarter, according to its most recent filing with the...

Addus HomeCare (NASDAQ:ADUS) Cut to Buy at Wall Street Zen

Wall Street Zen cut shares of Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Sunday...

Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February...

Addus HomeCare (NASDAQ:ADUS) Raised to "Strong-Buy" at Wall Street Zen

Wall Street Zen upgraded shares of Addus HomeCare from a "buy" rating to a "strong-buy" rating in a report on Saturday...

Principal Financial Group Inc. Sells 44,761 Shares of Addus HomeCare Corporation $ADUS

Principal Financial Group Inc. lessened its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 9.3% in the third quarter, according to the company in its most recent...

Addus HomeCare Corporation $ADUS Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lessened its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 91.1% in the 3rd quarter, according to the company in its most...

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded 1979 and is headquartered in Frisco, TX.

Addus HomeCare Corporation

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

Current Price	$112.44
Prev Close	$113.26
Open	$112.36
Dividend Yield	0.00%
50-Day Moving Average	$110.01
Beta	0.56
Avg. Volume	199,254.65
PE Ratio	24.24

52-Week High	$124.44
52-Week Low	$88.96
Market Capitalization	$2.09B
EPS (Annual)	$4.23
Price to Book	1.99
Revenue Per Employee	$23,229.97

ADUS
Addus HomeCare Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADUS News

ADUSAddus HomeCare Corporation